Animal testing is slow, expensive, and controversial. Enter AI. The US toxicology consulting market forecast predicts that AI‑driven risk assessment tools will be the fastest‑growing sub‑segment, with a CAGR above 20%. Machine learning models can predict a chemical's toxicity based on its molecular structure, without a single rat.

What's already working? Models for skin sensitisation, eye irritation, and mutagenicity are highly accurate. The US toxicology consulting market analysis notes that regulatory agencies like the EPA are now accepting in silico data for some endpoints. That's a game‑changer for the cosmetics industry, which faces animal testing bans in many countries.

But AI isn't ready for everything. Complex endpoints like carcinogenicity or reproductive toxicity still need animal or human data. And models are only as good as their training data — biased data leads to biased predictions.

The takeaway: AI will augment, not replace, toxicologists. The future is hybrid: computational screening first, followed by targeted testing. That means fewer animals, faster decisions, and lower costs.

❓ Frequently Asked Questions — US Toxicology Consulting Market